Life and death of circulating cell-free DNA

References

• Nehmat H, Nehmat H. Overdiagnosis of breast cancer in population screening: does it make breast screening worthless? Cancer Biol Med. 2017;14(1):1–8. doi:10.20892/j.issn.2095-3941.2016.0050.
   PubMed Web of Science ®Google Scholar
• Autier P, Boniol M, Koechlin A, Pizot C, Boniol M. Effectiveness of and overdiagnosis from mammography screening in the Netherlands: population based study. Bmj. 2017;j5224. doi:10.1136/bmj.j5224.
   PubMed Web of Science ®Google Scholar
• Salvi S, Gurioli G, De Giorgi U, Conteduca V, Tedaldi G, Calistri D, Casadio V. Cell-free DNA as a diagnostic marker for cancer: current insights. Onco Targets Ther. 2016;9:6549–6559. doi:10.2147/OTT.S100901.
   PubMed Web of Science ®Google Scholar
• Donaldson J, Bh P. Circulating tumor DNA: measurement and clinical utility. Annu Rev Med. 2018;69(1):1–512. doi:10.1146/annurev-med-041316-085721.
   PubMed Web of Science ®Google Scholar
• Bellairs JA, Hasina R, Agrawal N. Tumor DNA: an emerging biomarker in head and neck cancer. Cancer Metastasis Rev. 2017;36(3):515–523. doi:10.1007/s10555-017-9685-x.
   PubMed Web of Science ®Google Scholar
• Crowley E, Di Nicolantonio F, Loupakis F, Bardelli A. Liquid biopsy: monitoring cancer-genetics in the blood. Nat Rev Clin Oncol. 2013;10(8):472–484. doi:10.1038/nrclinonc.2013.110.
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H, Hoon DSB, Pantel K. Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer. 2011;11(6):426–437. doi:10.1038/nrc3066.
   PubMed Web of Science ®Google Scholar
• Lipinski KA, Barber LJ, Davies MN, Ashenden M, Sottoriva A, Gerlinger M. Cancer evolution and the limits of predictability in precision cancer medicine. Trends in Cancer. 2016;2(1):49–63. doi:10.1016/j.trecan.2015.11.003.
   PubMed Web of Science ®Google Scholar
• Bennett CW, Berchem G, Kim YJ, El-Khoury V. Cell-free DNA and next-generation sequencing in the service of personalized medicine for lung cancer. Oncotarget. 2015;7(September):71013–71035. doi:10.18632/oncotarget.11717.
   Google Scholar
• Rapisuwon S, Vietsch EE, Wellstein A. Circulating biomarkers to monitor cancer progression and treatment. Comput Struct Biotechnol J. 2016;14:211–222. doi:10.1016/j.csbj.2016.05.004.
   PubMed Web of Science ®Google Scholar
• Siravegna G, Marsoni S, Siena S, Bardelli A. Integrating liquid biopsies into the management of cancer. Nat Rev Clin Oncol. 2017;14(9):531–548. doi:10.1038/nrclinonc.2017.14.
   PubMed Web of Science ®Google Scholar
• Chen Y, Guo W, Fan J, et al. The applications of liquid biopsy in resistance surveillance of anaplastic lymphoma kinase inhibitor. Cancer Manag Res. 2017;9:801–811. doi:10.2147/CMAR.S151235.
   PubMed Web of Science ®Google Scholar
• Thiele J-A, Bethel K, Králíčková M, Kuhn P. Circulating tumor cells: fluid surrogates of solid tumors. Annu Rev Pathol Mech Dis. 2017;12(1):419–447. doi:10.1146/annurev-pathol-052016-100256.
   PubMed Web of Science ®Google Scholar
• Kowalik A, Kowalewska M, Góźdź S. Current approaches for avoiding the limitations of circulating tumor cells detection methods—implications for diagnosis and treatment of patients with solid tumors. Transl Res. 2017;185:58–84.e15. doi:10.1016/j.trsl.2017.04.002.
   PubMed Web of Science ®Google Scholar
• Endzelinš E, Berger A, Melne V, et al. Detection of circulating miRNAs: comparative analysis of extracellular vesicle-incorporated miRNAs and cell-free miRNAs in whole plasma of prostate cancer patients. BMC Cancer. 2017;17(1):1–13. doi:10.1186/s12885-017-3737-z.
   PubMed Web of Science ®Google Scholar
• Ma X, Zhu L, Wu X, et al. Cell-free DNA provides a good representation of the tumor genome despite its biased fragmentation patterns. PLoS One. 2017;12(1):1–18. doi:10.1371/journal.pone.0169231.
   Web of Science ®Google Scholar
• Garcia-Romero N, Esteban-Rubio S, Rackov G, Carrión-Navarro J, Belda-Iniesta C, Ayuso-Sacido A. Extracellular vesicles compartment in liquid biopsies: clinical application. Mol Aspects Med. 2017;60:27–37. doi:10.1016/j.mam.2017.11.009.
   PubMed Web of Science ®Google Scholar
• McAnena P, Brown JAL, Kerin MJ. Circulating nucleosomes and nucleosome modifications as biomarkers in cancer. Cancers (Basel). 2017;9(1):5. doi:10.3390/cancers9010005.
   PubMed Web of Science ®Google Scholar
• Rahier JF, Druez A, Faugeras L, et al. Circulating nucleosomes as new blood-based biomarkers for detection of colorectal cancer. Clin Epigenetics. 2017;9(1):1–7. doi:10.1186/s13148-017-0351-5.
   PubMed Web of Science ®Google Scholar
• Schwarzenbach H. Clinical relevance of circulating, cell-free and exosomal microRNAs in plasma and serum of breast cancer patients. Oncol Res Treat. 2017;40:423–429. doi:10.1159/000478019.
   PubMed Web of Science ®Google Scholar
• Palmirotta R, Lovero D, Cafforio P, Felici C, Mannavola F, Pellè E, Quaresmini D, Tucci M, Silvestris F. Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology. Ther Adv Med Oncol. 2018;10:1–24. doi:10.1177/1758835918794630.
   Web of Science ®Google Scholar
• Lo YMD, Lam WKJ. Tracing the tissue of origin of plasma DNA—feasibility and implications. Ann N Y Acad Sci. 2016;1376(1):14–17. doi:10.1111/nyas.13163.
   PubMed Web of Science ®Google Scholar
• Tie J, Wang Y, Tomasetti C, et al. Circulating tumor DNA analysis detects minimal residual disease and predicts recurrence in patients with stage II colon cancer. Sci Transl Med. 2016;8(346):346ra92. doi:10.1126/scitranslmed.aaf6219.Circulating.
   PubMed Web of Science ®Google Scholar
• Thierry AR, El Messaoudi S, Gahan PB, Anker P, Stroun M. Origins, structures, and functions of circulating DNA in oncology. Cancer Metastasis Rev. 2016;35(3):347–376. doi:10.1007/s10555-016-9629-x.
   PubMed Web of Science ®Google Scholar
• Muhanna N, Di Grappa MA, Chan HHL, Khan T, Jin CS, Zheng Y, Irish JC, Bratman SV. Cell-free DNA kinetics in a pre-clinical model of head and neck cancer. Sci Rep. 2017;7(1):16723. doi:10.1038/s41598-017-17079-6.
   PubMed Web of Science ®Google Scholar
• Bartels S, Persing S, Hasemeier B, Schipper E, Kreipe H, Lehmann U. Molecular analysis of circulating free DNA from lung cancer patients in routine laboratory practice. J Mol Diagnostics. 2017;19(5):722–732. doi:10.1016/j.jmoldx.2017.05.008.
   PubMed Web of Science ®Google Scholar
• Heitzer E, Haque IS, Roberts CE, Speicher MR. Current and future perspectives of liquid biopsies in genomics-driven oncology. Nat Rev Genet. doi:10.1038/s41576-018-0071-5.
   Web of Science ®Google Scholar
• Corcoran RB, Chabner BA. Application of cell-free DNA analysis to cancer treatment. N Engl J Med. 2018;379:1754–1765. doi:10.1056/NEJMra1706174.
   PubMed Web of Science ®Google Scholar
• Merker JD, Oxnard GR, Compton C, et al. Circulating tumor DNA analysis in patients with cancer: American Society of Clinical Oncology and College of American Pathologists joint review. J Clin Oncol. 2018;JCO.2017.76.867. doi:10.1200/JCO.2017.76.8671.
   PubMed Web of Science ®Google Scholar
• Mandel P, Metais P. Les acides nucléiques du plasma sanguin chez l’homme. C R Seances Soc Biol Ses Fil. 1948. doi:10.1007/BF00832140.
   Google Scholar
• Leon SA, Shapiro B, Sklaroff DM, et al. Free DNA in the serum of cancer patients and the effect of therapy free DNA in the serum of cancer patients and the effect of therapy. Cancer Res. 1977;37(March):646–650.
   PubMed Web of Science ®Google Scholar
• Zhu YJ, Zhang HB, Liu YH, Zhang F-L, Zhu Y-Z, Li Y, Bai J-P, Liu L-R, Qu Y-C, Qu X, et al. Quantitative cell-free circulating EGFR mutation concentration is correlated with tumor burden in advanced NSCLC patients. Lung Cancer. 2017;109(March):124–127. doi:10.1016/j.lungcan.2017.05.005.
   PubMed Web of Science ®Google Scholar
• Sharon E, Shi H, Kharbanda S, et al. Quantification of transplant-derived circulating cell-free DNA in absence of a donor genotype. PLoS Comput Biol. 2017;13(8):e1005629. doi:10.1371/journal.pcbi.1005629.
   PubMed Web of Science ®Google Scholar
• Burnham P, Khush K, De Vlaminck I. Myriad applications of circulating cell-free DNA in precision organ transplant monitoring. Ann Am Thorac Soc. 2017;14(7):S237–S241. doi:10.1513/AnnalsATS.201608-634MG.
   PubMed Web of Science ®Google Scholar
• Tug S, Helmig S, Deichmann ER, Schmeier-Jürchott A, Wagner E, Zimmermann T, Radsak M, Giacca M, Simon P. Exercise-induced increases in cell free DNA in human plasma originate predominantly from cells of the haematopoietic lineage. Exerc Immunol Rev. 2015;21(27):164–173.
   PubMed Web of Science ®Google Scholar
• Breitbach S, Tug S, Helmig S, Zahn D, Kubiak T, Michal M, Gori T, Ehlert T, Beiter T, Simon P, et al. Direct quantification of cell-free, circulating DNA from unpurified plasma. PLoS One. 2014;9(3):e87838. doi:10.1371/journal.pone.0087838.
   PubMed Web of Science ®Google Scholar
• O’Connell GC, Petrone AB, Tennant CS, Lucke-Wold N, Kabbani Y, Tarabishy AR, Chantler PD, Barr TL. Circulating extracellular DNA levels are acutely elevated in ischaemic stroke and associated with innate immune system activation. Brain Inj. 2017;31(10):1369–1375. doi:10.1080/02699052.2017.1312018.
   PubMed Web of Science ®Google Scholar
• Wilson IJ, Burchell RK, Worth AJ, Burton SE, Gedye KR, Clark KJ, Crosse KR, Jack M, Odom TF, De Grey SJ, et al. Kinetics of plasma cell-free DNA and creatine kinase in a canine model of tissue injury. J Vet Intern Med. 2017;32(1):157–164. doi:10.1111/jvim.14901.
   PubMed Web of Science ®Google Scholar
• Volik S, Alcaide M, Morin RD, Collins C. Cell-free DNA (cfDNA): clinical significance and utility in cancer shaped by emerging technologies. Mol Cancer Res. 2016;14(10):898–908. doi:10.1158/1541-7786.MCR-16-0044.
   PubMed Web of Science ®Google Scholar
• Zill OA, Banks KC, Fairclough SR, Mortimer SA, Vowles JV, Mokhtari R, Gandara DR, Mack PC, Odegaard JI, Nagy RJ, et al. The landscape of actionable genomic alterations in cell-free circulating tumor DNA from 21,807 advanced cancer patients. Clinical Cancer Res. 2018;24:3528–3538. doi:10.1158/1078-0432.CCR-17-3837.
   PubMed Web of Science ®Google Scholar
• Bettegowda C, Sausen M, Leary R, Kinde I, Wang Y, Agrawal N, Bartlett BR, Wang H, Luber B, Alani RM, et al. Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med. 2014;6(224):224ra24. doi:10.1126/scitranslmed.3007094.Detection.
   PubMed Web of Science ®Google Scholar
• Khier S, Lohan L. Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature. Future Sci OA. 2018;4:FSO295. doi:10.4155/fsoa-2017-0140.
   PubMed Web of Science ®Google Scholar
• Myint NNM, Verma AM, Fernandez-Garcia D, et al. Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity. Cell Death Dis. 2018;9(9):894. doi:10.1038/s41419-018-0934-x.
   PubMed Web of Science ®Google Scholar
• Diehl F, Li M, Dressman D, He Y, Shen D, Szabo S, Diaz LA, Goodman SN, David KA, Juhl H, et al. Detection and quantification of mutations in the plasma of patients with colorectal tumors. Proc Natl Acad Sci. 2005;102(45):16368–16373. doi:10.1073/pnas.0507904102.
   PubMed Web of Science ®Google Scholar
• Xia L, Li Z, Zhou B, et al. Statistical analysis of mutant allele frequency level of circulating cell-free DNA and blood cells in healthy individuals. Sci Rep. 2017;7(1):1–7. doi:10.1038/s41598-017-06106-1.
   PubMed Web of Science ®Google Scholar
• Valpione S, Gremel G, Mundra P, Middlehurst P, Galvani E, Girotti MR, Lee RJ, Garner G, Dhomen N, Lorigan PC, et al. Plasma total cell-free DNA (cfDNA) is a surrogate biomarker for tumour burden and a prognostic biomarker for survival in metastatic melanoma patients. Eur J Cancer. 2018;88:1–9. doi:10.1016/j.ejca.2017.10.029.
   PubMed Web of Science ®Google Scholar
• Winther-Larsen A, Demuth C, Fledelius J, Madsen AT, Hjorthaug K, Meldgaard P, Sorensen BS. Correlation between circulating mutant DNA and metabolic tumour burden in advanced non-small cell lung cancer patients. Br J Cancer. 2017;117(5):704–709. doi:10.1038/bjc.2017.215.
   PubMed Web of Science ®Google Scholar
• Morbelli S, Alama A, Ferrarazzo G, et al. Circulating tumor DNA reflects tumor metabolism rather than tumor burden in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC): an 18 F-FDG PET/CT study. J Nucl Med. 2017;58(11):jnumed.117.193201. doi:10.2967/jnumed.117.193201.
   Web of Science ®Google Scholar
• Wong SQ, Raleigh JM, Callahan J, et al. Circulating tumor DNA analysis and functional imaging provide complementary approaches for comprehensive disease monitoring in metastatic melanoma. JCO Precis Oncol. 2017;(1):1–14. doi:10.1200/PO.16.00009.
   PubMed Web of Science ®Google Scholar
• Mcevoy AC, Warburton L, Al-Ogaili Z, et al. Correlation between circulating tumour DNA and metabolic tumour burden in metastatic melanoma patients. 2018;1–8.
   Google Scholar
• Cohen JD, Li L, Wang Y, Thoburn C, Afsari B, Danilova L, Douville C, Javed AA, Wong F, Mattox A, et al. Detection and localization of surgically resectable cancers with a multi-analyte blood test. Science (80-). 2018;359(6378):926–930. doi:10.1126/science.aar3247.
   PubMed Web of Science ®Google Scholar
• Lehmann-Werman R, Neiman D, Zemmour H, Moss J, Magenheim J, Vaknin-Dembinsky A, Rubertsson S, Nellgård B, Blennow K, Zetterberg H, et al. Identification of tissue-specific cell death using methylation patterns of circulating DNA. Proc Natl Acad Sci. 2016;113(13):E1826–E1834. doi:10.1073/pnas.1519286113.
   PubMed Web of Science ®Google Scholar
• Wu DC, Lambowitz AM. Facile single-stranded DNA sequencing of human plasma DNA via thermostable group II intron reverse transcriptase template switching OPEN. doi:10.1038/s41598-017-09064-w.
   Google Scholar
• Moss J, Magenheim J, Neiman D, Zemmour H, Loyfer N, Korach A, Samet Y, Maoz M, Druid H, Arner P, et al. Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease. Nat Commun. 2018;9(1):5068. doi:10.1038/s41467-018-07466-6.
   PubMed Web of Science ®Google Scholar
• Wong FCK, Sun K, Jiang P, Cheng YKY, Chan KCA, Leung TY, Chiu RWK, Lo YMD. Cell-free DNA in maternal plasma and serum: a comparison of quantity, quality and tissue origin using genomic and epigenomic approaches. Clin Biochem. 2016;49(18):1379–1386. doi:10.1016/j.clinbiochem.2016.09.009.
   PubMed Web of Science ®Google Scholar
• Snyder MW, Kircher M, Hill AJ, Daza RM, Shendure J. Cell-free DNA comprises an in vivo nucleosome footprint that informs its tissues-of-origin. Cell. 2016;164(1–2):57–68. doi:10.1016/j.cell.2015.11.050.Cell-free.
   PubMed Web of Science ®Google Scholar
• Ivanov M, Baranova A, Butler T, Spellman P, Mileyko V. Non-random fragmentation patterns in circulating cell-free DNA reflect epigenetic regulation. BMC Genomics. 2015;16(13):1–12. doi:10.1186/1471-2164-16-S13-S1.
   PubMed Web of Science ®Google Scholar
• Zhang W, Xia W, Lv Z, Ni C, Xin Y, Yang L. Liquid biopsy for cancer: circulating tumor cells, circulating free DNA or exosomes? Cell Physiol Biochem. 2017;41(2):755–768. doi:10.1159/000458736.
   PubMed Web of Science ®Google Scholar
• Neumann MHD, Bender S, Krahn T, Schlange T. ctDNA and CTCs in liquid biopsy – current status and where we need to progress. Comput Struct Biotechnol J. 2018;16:190–195. doi:10.1016/J.CSBJ.2018.05.002.
   PubMed Web of Science ®Google Scholar
• Murtaza M, Dawson SJ, Pogrebniak K, Rueda OM, Provenzano E, Grant J, Chin S-F, Tsui DWY, Marass F, Gale D, et al. Multifocal clonal evolution characterized using circulating tumour DNA in a case of metastatic breast cancer. Nat Commun. 2015;6:1–6. doi:10.1038/ncomms9760.
   Web of Science ®Google Scholar
• Mouliere F, Thierry AR. The importance of examining the proportion of circulating DNA originating from tumor, microenvironment and normal cells in colorectal cancer patients. Expert Opin Biol Ther. 2012;12(sup1):S209–S215. doi:10.1517/14712598.2012.688023.
   PubMed Web of Science ®Google Scholar
• Ulz P, Thallinger GG, Auer M, Graf R, Kashofer K, Jahn SW, Abete L, Pristauz G, Petru E, Geigl JB, et al. Inferring expressed genes by whole-genome sequencing of plasma DNA. Nat Genet. 2016;48(10):1273–1278. doi:10.1038/ng.3648.
   PubMed Web of Science ®Google Scholar
• Lam WKJ, Gai W, Sun K, Wong RSM, Chan RWY, Jiang P, Chan NPH, Hui WWI, Chan AWH, Szeto -C-C, et al. DNA of erythroid origin is present in human plasma and informs the types of anemia. Clin Chem. 2017;63:1614–1623. doi:10.1373/clinchem.2017.272401.
   PubMed Web of Science ®Google Scholar
• Fleischhacker M, Schmidt B. Circulating nucleic acids (CNAs) and cancer: a survey. Biochim Biophys Acta - Rev Cancer. 2007;1775(1):181–232. doi:10.1016/j.bbcan.2006.10.001.
   PubMed Web of Science ®Google Scholar
• Jiang P, Chan CWM, Chan KCA, et al. Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients. Proc Natl Acad Sci. 2015;112(11):E1317–E1325. doi:10.1073/pnas.1500076112.
   PubMed Web of Science ®Google Scholar
• Kumar M, Srivastava S, Singh SA, Das AK, Das GC, Dhar B, Ghosh SK, Mondal R. Cell-free mitochondrial DNA copy number variation in head and neck squamous cell carcinoma: a study of non-invasive biomarker from Northeast India. Tumor Biol. 2017;39(10):1–9. doi:10.1177/1010428317736643.
   Google Scholar
• Fernandes J, Michel V, Camorlinga-Ponce M, Gomez A, Maldonado C, De Reuse H, Torres J, Touati E. Circulating mitochondrial DNA level, a noninvasive biomarker for the early detection of gastric cancer. Cancer Epidemiol Biomarkers Prev. 2014;23(11):2430–2438. doi:10.1158/1055-9965.EPI-14-0471.
   PubMed Web of Science ®Google Scholar
• Holdenrieder S, Nagel D, Schalhorn A, Heinemann V, Wilkowski R, von Pawel J, Raith H, Feldmann K, Kremer AE, Müller S, et al. Clinical relevance of circulating nucleosomes in cancer. Ann N Y Acad Sci. 2008;1137:180–189. doi:10.1196/annals.1448.012.
   PubMed Web of Science ®Google Scholar
• Torralba D, Baixauli F, Villarroya-Beltri C, et al. Priming of dendritic cells by DNA-containing extracellular vesicles from activated T cells through antigen-driven contacts. Nat Commun. 2018;9(1):1–17. doi:10.1038/s41467-018-05077-9.
   PubMed Web of Science ®Google Scholar
• Fernando MR, Jiang C, Krzyzanowski GD, Ryan WL. New evidence that a large proportion of human blood plasma cell-free DNA is localized in exosomes. PLoS One. 2017;12(8):1–15. doi:10.1371/journal.pone.0183915.
   Web of Science ®Google Scholar
• Vagner T, Spinelli C, Minciacchi VR, Balaj L, Zandian M, Conley A, Zijlstra A, Freeman MR, Demichelis F, De S, et al. Large extracellular vesicles carry most of the tumour DNA circulating in prostate cancer patient plasma. J Extracell Vesicles. 2018;7(1):1505403. doi:10.1080/20013078.2018.1505403.
   PubMed Web of Science ®Google Scholar
• Thakur BK, Zhang H, Becker A, Matei I, Huang Y, Costa-Silva B, Zheng Y, Hoshino A, Brazier H, Xiang J, et al. Double-stranded DNA in exosomes: a novel biomarker in cancer detection. Cell Res. 2014;24(6):766–769. doi:10.1038/cr.2014.44.
   PubMed Web of Science ®Google Scholar
• Wang W, Kong P, Ma G, Li L, Zhu J, Xia T, Xie H, Zhou W, Wang S. Characterization of the release and biological significance of cell-free DNA from breast cancer cell lines. Oncotarget. 2017;8(26):43180–43191. doi:10.18632/oncotarget.17858.
   PubMedGoogle Scholar
• Zhang R, Nakahira K, Guo X, Choi AMK, Gu Z. Very short mitochondrial DNA fragments and heteroplasmy in human plasma. Sci Rep. 2016;6:1–10. doi:10.1038/srep36097.
   PubMed Web of Science ®Google Scholar
• Mouliere F, Chandrananda D, Piskorz AM, et al. Enhanced detection of circulating tumor DNA by fragment size analysis. Sci Transl Med. 2018;10(466):eaat4921. doi:10.1126/scitranslmed.aat4921.
   PubMed Web of Science ®Google Scholar
• Agostini M, Pucciarelli S, Enzo MV, Del Bianco P, Briarava M, Bedin C, Maretto I, Friso ML, Lonardi S, Mescoli C, et al. Circulating cell-free DNA: a promising marker of pathologic tumor response in rectal cancer patients receiving preoperative chemoradiotherapy. Ann Surg Oncol. 2011;18(9):2461–2468. doi:10.1245/s10434-011-1638-y.
   PubMed Web of Science ®Google Scholar
• Beyer C, Stearns NA, Giessl A, Distler JHW, Schett G, Pisetsky DS. The extracellular release of DNA and HMGB1 from Jurkat T cells during in vitro necrotic cell death. Innate Immun. 2012;18(5):727–737. doi:10.1177/1753425912437981.
   PubMed Web of Science ®Google Scholar
• Beyer C, Pisetsky DS. Modeling nuclear molecule release during in vitro cell death. Autoimmunity. 2013;46(5):298–301. doi:10.3109/08916934.2012.750297.
   PubMed Web of Science ®Google Scholar
• Cheng C, Omura-Minamisawa M, Kang Y, Hara T, Koike I, Inoue T. Quantification of circulating cell-free DNA in the plasma of cancer patients during radiation therapy. Cancer Sci. 2009;100(2):303–309. doi:10.1111/j.1349-7006.2008.01021.x.
   PubMed Web of Science ®Google Scholar
• Mouliere F, Piskorz AM, Chandrananda D, et al. Selecting short DNA fragments in plasma improves detection of circulating tumour DNA. bioRxiv. 2017;134437. doi:10.1101/134437.
   Google Scholar
• Underhill HR, Kitzman JO, Hellwig S, Welker NC, Daza R, Baker DN, Gligorich KM, Rostomily RC, Bronner MP, Shendure J, et al. Fragment length of circulating tumor DNA. PLoS Genet. 2016;12(7):1–24. doi:10.1371/journal.pgen.1006162.
   Web of Science ®Google Scholar
• Cherepanova AV, Tamkovich SN, Bryzgunova OE, Vlassov VV, Laktionov PP. Deoxyribonuclease activity and circulating DNA concentration in blood plasma of patients with prostate tumors. Ann N Y Acad Sci. 2008;1137:218–221. doi:10.1196/annals.1448.016.
   PubMed Web of Science ®Google Scholar
• Chen H, Sun L, Zheng H, Zhang Q, Jin X. Total serum DNA and DNA integrity: diagnostic value in patients with hepatitis B virus-related hepatocellular carcinoma. Pathology. 2012;44(4):318–324. doi:10.1097/PAT.0b013e328353a24c.
   Web of Science ®Google Scholar
• Gang F, Guorong L, An Z, Anne GP, Christian G, Jacques T. Prediction of clear cell renal cell carcinoma by integrity of cell-free DNA in serum. Urology. 2010;75(2):262–265. doi:10.1016/j.urology.2009.06.048.
   PubMed Web of Science ®Google Scholar
• Bronkhorst AJ, Wentzel JF, Aucamp J, van Dyk E, Du Plessis L, Pretorius PJ. Characterization of the cell-free DNA released by cultured cancer cells. Biochim Biophys Acta - Mol Cell Res. 2016;1863(1):157–165. doi:10.1016/j.bbamcr.2015.10.022.
   PubMed Web of Science ®Google Scholar
• Roy S, Coldren C, Karunamurthy A, Kip NS, Klee EW, Lincoln SE, Leon A, Pullambhatla M, Temple-Smolkin RL, Voelkerding KV, et al. Standards and guidelines for validating next-generation sequencing bioinformatics pipelines: a joint recommendation of the Association for Molecular Pathology and the College of American Pathologists. J Mol Diagnostics. 2018;20(1):4–27. doi:10.1016/j.jmoldx.2017.11.003.
   PubMed Web of Science ®Google Scholar
• Miao EA, Rajan JV, Aderem A. Caspase-1-induced pyroptotic cell death. Immunol Rev. 2011;243(1):206–214. doi:10.1111/j.1600-065X.2011.01044.x.
   PubMed Web of Science ®Google Scholar
• Kemp MG, Reardon JT, Lindsey-Boltz LA, Sancar A. Mechanism of release and fate of excised oligonucleotides during nucleotide excision repair. J Biol Chem. 2012;287(27):22889–22899. doi:10.1074/jbc.M112.374447.
   PubMed Web of Science ®Google Scholar
• Peters DL, Pretorius PJ. Origin, translocation and destination of extracellular occurring DNA - a new paradigm in genetic behaviour. Clin Chim Acta. 2011;412(11–12):806–811. doi:10.1016/j.cca.2011.01.026.
   PubMed Web of Science ®Google Scholar
• Moras M, Lefevre SD, Ostuni MA. From erythroblasts to mature red blood cells: organelle clearance in mammals. Front Physiol. 2017;8(DEC):1–9. doi:10.3389/fphys.2017.01076.
   PubMed Web of Science ®Google Scholar
• Yipp BG, Petri B, Salina D, et al. Dynamic NETosis is carried out by live neutrophils in human and mouse bacterial abscesses and during severe gram-positive infection. Nat Med. 2012;18(9):1386–1393. doi:10.1038/nm.2847.
   PubMed Web of Science ®Google Scholar
• Sansone P, Savini C, Kurelac I, et al. Packaging and transfer of mitochondrial DNA via exosomes regulate escape from dormancy in hormonal therapy-resistant breast cancer. Proc Natl Acad Sci. 2017;11:E9066–E9075. doi:10.1073/pnas.1704862114.
   Web of Science ®Google Scholar
• Ingelsson B, Söderberg D, Strid T, Söderberg A, Bergh A-C, Loitto V, Lotfi K, Segelmark M, Spyrou G, Rosén A. Lymphocytes eject interferogenic mitochondrial DNA webs in response to CpG and non-CpG oligodeoxynucleotides of class C. Proc Natl Acad Sci. 2018;115(3):E478–E487. doi:10.1073/pnas.1711950115.
   PubMed Web of Science ®Google Scholar
• Marsman G, Zeerleder S, Luken BM. Extracellular histones, cell-free DNA, or nucleosomes: differences in immunostimulation. Cell Death Dis. 2016;7(12):e2518. doi:10.1038/cddis.2016.410.
   PubMed Web of Science ®Google Scholar
• Demers M, Wagner DD. NETosis: a new factor in tumor progression and cancer- associated thrombosis. Semin Thromb Hemost. 2014;40(3):277–283. doi:10.1055/s-0034-1370765.NETosis.
   PubMed Web of Science ®Google Scholar
• Yang H, Biermann MH, Brauner JM, Liu Y, Zhao Y, Herrmann M. New insights into neutrophil extracellular traps: mechanisms of formation and role in inflammation. Front Immunol. 2016;7(AUG):1–8. doi:10.3389/fimmu.2016.00302.
   PubMed Web of Science ®Google Scholar
• Kazzaz NM, Sule G, Knight JS, Knight JS. Intercellular interactions as regulators of NETosis. 2016;7(November):1–11. doi:10.3389/fimmu.2016.00453.
   Google Scholar
• Kappelmayer J, Jr BN. The interaction of selectins and PSGL-1 as a key component in thrombus formation and cancer progression. 2017;2017:6138145.
   Google Scholar
• Chiu RWK, Chan LYS, Lam NYL, et al. Quantitative analysis of circulating mitochondrial DNA in plasma. Clin Chem. 2003;49(5):719–726. doi:10.1373/49.5.719.
   PubMed Web of Science ®Google Scholar
• Wang H, Li T, Chen S, Gu Y, Ye S. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin. Arthritis Rheumatol. 2015;67(12):3190–3200. doi:10.1002/art.39296.
   PubMed Web of Science ®Google Scholar
• Itagaki K, Kaczmarek E, Lee YT, et al. Mitochondrial DNA released by trauma induces neutrophil extracellular traps. PLoS One. 2015;10(3):1–10. doi:10.1371/journal.pone.0120549.
   Web of Science ®Google Scholar
• Leung F, Kulasingam V, Diamandis EP, et al. Circulating tumor DNA as a cancer biomarker: fact or fiction? Clin Chem. 2016;62(8):1054–1060. doi:10.1373/clinchem.2016.260331.
   PubMed Web of Science ®Google Scholar
• Celec P, Vlková B, Lauková L, Bábíčková J, Boor P. Cell-free DNA: the role in pathophysiology and as a biomarker in kidney diseases. Expert Rev Mol Med. 2018;20:1–14. doi:10.1017/erm.2017.12.
   Web of Science ®Google Scholar
• Thierry AR, Mouliere F, Gongora C, et al. Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res. 2010;38(18):6159–6175. doi:10.1093/nar/gkq421.
   PubMed Web of Science ®Google Scholar
• García Moreira V, De La Cera Martínez T, Gago González E, Prieto García B, Alvarez Menéndez FV. Increase in and clearance of cell-free plasma DNA in hemodialysis quantified by real-time PCR. Clin Chem Lab Med. 2006;44(12):1410–1415. doi:10.1515/CCLM.2006.252.
   PubMed Web of Science ®Google Scholar
• Gauthier VJ, Tyler LN, Mannik M. Blood clearance kinetics and liver uptake of mononucleosomes in mice. J Immunol. 1996;156(3):1151–1156.
   PubMed Web of Science ®Google Scholar
• Yu SCY, Lee SWY, Jiang P, et al. High-resolution profiling of fetal DNA clearance from maternal plasma by massively parallel sequencing. Clin Chem. 2013;59(8):1228–1237. doi:10.1373/clinchem.2013.203679.
   PubMed Web of Science ®Google Scholar
• Diehl F, Schmidt K, Choti MA, et al. Circulating mutant DNA to assess tumor dynamics. Nat Med. 2008;14(9):985–990. doi:10.1038/nm.1789.
   PubMed Web of Science ®Google Scholar
• Stephan F, Marsman G, Bakker LM, et al. Cooperation of factor vii-activating protease and serum DNase I in the release of nucleosomes from necrotic cells. Arthritis Rheumatol. 2014;66(3):686–693. doi:10.1002/art.38265.
   PubMed Web of Science ®Google Scholar
• Martin M, Leffler J, Smolag KI, et al. Factor H uptake regulates intracellular C3 activation during apoptosis and decreases the inflammatory potential of nucleosomes. Cell Death Differ. 2016;23(5):903–911. doi:10.1038/cdd.2015.164.
   PubMed Web of Science ®Google Scholar
• Tamkovich SN, Cherepanova A V., Kolesnikova E V., et al. Circulating DNA and DNase activity in human blood. Ann N Y Acad Sci. 2006;1075:191–196. doi:10.1196/annals.1368.026.
   PubMed Web of Science ®Google Scholar
• Butler TM, Spellman PT, Gray J. Circulating-tumor DNA as an early detection and diagnostic tool. Curr Opin Genet Dev. 2017;42:14–21. doi:10.1016/j.gde.2016.12.003.
   PubMed Web of Science ®Google Scholar
• Du Clos TW, Volzer MA, Hahn FF, Xiao R, Mold C, Searles RP. Chromatin clearance in C57B1/10 mice: interaction with heparan sulphate proteoglycans and receptors on Kupffer cells. Clin Exp Immunol. 1999;117(2):403–411. doi:10.1046/j.1365-2249.1999.00976.x.
   PubMed Web of Science ®Google Scholar
• Koizumi T. Tissue distribution of deoxyribonuclease I (DNase I) activity level in mice and its sexual dimorphism. Exp Anim. 1995;44(3):181–185. doi:10.1538/expanim.44.181.
   PubMed Web of Science ®Google Scholar
• Abrams ST, Zhang N, Manson J, et al. Circulating histones are mediators of trauma-associated lung injury. Am J Respir Crit Care Med. 2013;187(2):160–169. doi:10.1164/rccm.201206-1037OC.
   PubMed Web of Science ®Google Scholar
• Xu J, Zhang X, Pelayo R, et al. Extracellular histones are major mediators of death in sepsis. Nat Med. 2009;15(11):1318–1321. doi:10.1038/nm.2053.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Raoof M, Chen Y, Sumi Y, Sursal T, Junger W, Brohi K, Itagaki K, Hauser CJ. Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature. 2010;464(7285):104–107. doi:10.1038/nature08780.
   PubMed Web of Science ®Google Scholar
• Paunel-Görgülü A, Wacker M, El Aita M, Hassan S, Schlachtenberger G, Deppe A, Choi Y-H, Kuhn E, Mehler TO, Wahlers T. cfDNA correlates with endothelial damage after cardiac surgery with prolonged cardiopulmonary bypass and amplifies NETosis in an intracellular TLR9-independent manner. Sci Rep. 2017;7(1):17421. doi:10.1038/s41598-017-17561-1.
   PubMed Web of Science ®Google Scholar
• Bhagirath VC, Dwivedi DJ, Liaw PC. Comparison of the proinflammatory and procoagulant properties of nuclear, mitochondrial, and bacterial DNA. Shock. 2015;44(3):265–271. doi:10.1097/SHK.0000000000000397.
   PubMed Web of Science ®Google Scholar
• Xu MM, Pu Y, Han D, Shi Y, Cao X, Liang H, Chen X, Li X-D, Deng L, Chen ZJ, et al. Dendritic cells but not macrophages sense tumor mitochondrial DNA for cross-priming through signal regulatory protein α signaling. Immunity. 2017;47(2):363–373.e5. doi:10.1016/j.immuni.2017.07.016.
   PubMed Web of Science ®Google Scholar
• Nishimoto S, Fukuda D, Higashikuni Y, et al. Obesity-induced DNA released from adipocytes stimulates chronic adipose tissue inflammation and insulin resistance. 2016;6(March):1–11.
   Google Scholar
• Corrêa LH, Corrêa R, Farinasso CM, Pimentel L, Dourado DSA, Magalhães KG. Adipocytes and macrophages interplay in the orchestration of tumor microenvironment: new implications in cancer progression. 2017;8(September):1–12. doi:10.3389/fimmu.2017.01129.
   Google Scholar
• Dunphy G, Flannery SM, Almine JF, Connolly DJ, Paulus C, Jønsson KL, Jakobsen MR, Nevels MM, Bowie AG, Unterholzner L. Non-canonical activation of the DNA sensing adaptor STING by ATM and IFI16 mediates NF-κB signaling after nuclear DNA damage. Mol Cell. 2018;71(5):745–760.e5. doi:10.1016/j.molcel.2018.07.034.
   PubMed Web of Science ®Google Scholar
• Parkes EE, Walker SM, Taggart LE, et al. Activation of STING-dependent innate immune signaling by s-phase-specific DNA damage in breast cancer. J Natl Cancer Inst. 2017;109:1. doi:10.1093/jnci/djw199.
   Google Scholar
• Ahn J, Xia T, Konno H, Konno K, Ruiz P, Barber GN. Inflammation-driven carcinogenesis is mediated through STING. Nat Commun. 2014;5:1–9. doi:10.1038/ncomms6166.
   Web of Science ®Google Scholar
• Härtlova A, Erttmann SF, Raffi FAM, Schmalz AM, Resch U, Anugula S, Lienenklaus S, Nilsson LM, Kröger A, Nilsson JA, et al. DNA damage primes the type I interferon system via the cytosolic DNA sensor STING to promote anti-microbial innate immunity. Immunity. 2015;42(2):332–343. doi:10.1016/j.immuni.2015.01.012.
   PubMed Web of Science ®Google Scholar
• Chen G, Huang AC, Zhang W, Zhang G, Wu M, Xu W, Yu Z, Yang J, Wang B, Sun H, et al. Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response. Nature. 2018;560:382–386. doi:10.1038/s41586-018-0392-8.
   PubMed Web of Science ®Google Scholar
• Theodoraki M-N, Yerneni S, Hoffmann TK, Gooding WE, Whiteside TL. Clinical significance of PD-L1+ exosomes in plasma of head and neck cancer patients. Clin Cancer Res. 2017;24(4):clincanres.2664.2017. doi:10.1158/1078-0432.CCR-17-2664.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li CW, Chan LC, et al. Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth. Cell Res. 2018;(January):1–3. doi:10.1038/s41422-018-0060-4.
   PubMed Web of Science ®Google Scholar
• Cabel L, Riva F, Servois V, Livartowski A, Daniel C, Rampanou A, Lantz O, Romano E, Milder M, Buecher B, et al. Circulating tumor DNA changes for early monitoring of anti-PD1 immunotherapy: a proof-of-concept study. Ann Oncol. 2017;28:1996–2001. doi:10.1093/annonc/mdx212.
   PubMed Web of Science ®Google Scholar
• Kim ST, Cristescu R, Bass AJ, Kim K-M, Odegaard JI, Kim K, Liu XQ, Sher X, Jung H, Lee M, et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat Med. 2018;24(9):1449–1458. doi:10.1038/s41591-018-0101-z.
   PubMed Web of Science ®Google Scholar
• Raja R, Kuziora M, Brohawn PZ, Higgs BW, Gupta A, Dennis PA, Ranade K. Early reduction in ctDNA predicts survival in patients with lung and bladder cancer treated with durvalumab. Clin Cancer Res. 2018;24(24):6212–6222. doi:10.1158/1078-0432.CCR-18-0386.
   PubMed Web of Science ®Google Scholar
• Takahashi A, Okada R, Nagao K, et al. Exosomes maintain cellular homeostasis by excreting harmful DNA from cells. Nat Commun. 2017;8(May):1–14. doi:10.1038/ncomms15287.
   PubMed Web of Science ®Google Scholar
• Trejo-Becerril C, Pérez-Cárdenas E, Taja-Chayeb L, Anker P, Herrera-Goepfert R, Medina-Velázquez LA, Hidalgo-Miranda A, Pérez-Montiel D, Chávez-Blanco A, Cruz-Velázquez J, et al. Cancer progression mediated by horizontal gene transfer in an in vivo model. PLoS One. 2012;7(12):1–12. doi:10.1371/journal.pone.0052754.
   Web of Science ®Google Scholar
• García-Olmo D, García-Olmo DC, Ontañón J, Martinez E, Vallejo M. Tumor DNA circulating in the plasma might play a role in metastasis. The hypothesis of the genometastasis. Histol Histopathol. 1999;14(4):1159–1164. doi:10.14670/HH-14.1159.
   PubMed Web of Science ®Google Scholar
• Mittra I, Khare NK, Raghuram GV, Chaubal R, Khambatti F, Gupta D, Gaikwad A, Prasannan P, Singh A, Iyer A, et al. Circulating nucleic acids damage DNA of healthy cells by integrating into their genomes. J Biosci. 2015;40(1):91–111. doi:10.1007/s12038-015-9508-6.
   PubMed Web of Science ®Google Scholar
• García-Casas A, García-Olmo DC, García-Olmo D. Further the liquid biopsy: gathering pieces of the puzzle of genometastasis theory. World J Clin Oncol. 2017;8(5):378–388. doi:10.5306/wjco.v8.i5.378.
   PubMed Web of Science ®Google Scholar
• Furi I, Kalmár A, Wichmann B, Spisák S, Schöller A, Barták B, Tulassay Z, Molnár B, Castresana JS. Cell free DNA of tumor origin induces a “metastatic” expression profile in HT-29 cancer cell line. PLoS One. 2015;10(7):1–16. doi:10.1371/journal.pone.0131699.
   Web of Science ®Google Scholar
• Lee TH, Chennakrishnaiah S, Meehan B, et al. Barriers to horizontal cell transformation by extracellular vesicles containing oncogenic H-ras. Oncotarget. 2016;7(32):8–11. doi:10.18632/oncotarget.10627.
   Google Scholar
• Cai J, Han Y, Ren H, Chen C, He D, Zhou L, Eisner GM, Asico LD, Jose PA, Zeng C. Extracellular vesicle-mediated transfer of donor genomic DNA to recipient cells is a novel mechanism for genetic influence between cells. J Mol Cell Biol. 2013;5(4):227–238. doi:10.1093/jmcb/mjt011.
   PubMed Web of Science ®Google Scholar
• Islam MN, Das SR, Emin MT, Wei M, Sun L, Westphalen K, Rowlands DJ, Quadri SK, Bhattacharya S, Bhattacharya J. Mitochondrial transfer from bone-marrow-derived stromal cells to pulmonary alveoli protects against acute lung injury. Nat Med. 2012;18(5):759–765. doi:10.1038/nm.2736.
   PubMed Web of Science ®Google Scholar
• Liu K, Ji K, Guo L, Wu W, Lu H, Shan P, Yan C. Mesenchymal stem cells rescue injured endothelial cells in an in vitro ischemia-reperfusion model via tunneling nanotube like structure-mediated mitochondrial transfer. Microvasc Res. 2014;92:10–18. doi:10.1016/j.mvr.2014.01.008.
   PubMed Web of Science ®Google Scholar
• Guescini M, Genedani S, Stocchi V, Agnati LF. Astrocytes and glioblastoma cells release exosomes carrying mtDNA. J Neural Transm. 2010;117(1):1–4. doi:10.1007/s00702-009-0288-8.
   PubMed Web of Science ®Google Scholar
• Ling S, Martinod K, Gallant M, Cabral JE, Wang Y. Priming of neutrophils toward NETosis promotes tumor growth. 2016;5(5):1–9. doi:10.1080/2162402X.2015.1134073.
   Google Scholar
• Swystun LL, Mukherjee S, Liaw PC. Breast cancer chemotherapy induces the release of cell-free DNA, a novel procoagulant stimulus. J Thromb Haemost. 2011;9(11):2313–2321. doi:10.1111/j.1538-7836.2011.04465.x.
   PubMed Web of Science ®Google Scholar
• Olsson A, Cedervall J. NETosis in cancer – platelet–neutrophil crosstalk promotes tumor-associated pathology. 2016;7(September):2–9. doi:10.3389/fimmu.2016.00373.
   Google Scholar
• Tohme S, Yazdani HO, Al-Khafaji AB, Chidi AP, Loughran P, Mowen K, Wang Y, Simmons RL, Huang H, Tsung A. Neutrophil extracellular traps promote the development and progression of liver metastases after surgical stress. Cancer Res. 2016;76(6):1367–1380. doi:10.1158/0008-5472.CAN-15-1591.
   PubMed Web of Science ®Google Scholar
• Park J, Wysocki RW, Amoozgar Z, et al. Cancer cells induce metastasis-supporting neutrophil extracellular DNA traps. Cancer. 2016;8(361):361ra138.
   Google Scholar
• Erpenbeck L, Schön MP. Neutrophil extracellular traps: protagonists of cancer progression? Oncogene. 2017;36(18):2483–2490. doi:10.1038/onc.2016.406.
   PubMed Web of Science ®Google Scholar
• Albrengues J, Shields MA, Ng D, Park CG, Ambrico A, Poindexter ME, Upadhyay P, Uyeminami DL, Pommier A, Küttner V, et al. Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science (80-). 2018;361:6409. doi:10.1126/science.aao4227.
   Web of Science ®Google Scholar
• Mouchemore KA, Anderson RL, Hamilton JA. Neutrophils, G-CSF and their contribution to breast cancer metastasis. FEBS J. 2017;285:665–679. doi:10.1111/febs.14206.
   PubMed Web of Science ®Google Scholar
• Cedervall J, Olsson A. NETosis in cancer. Oncoscience. 2015;2(11):11–12.
   Google Scholar
• Etulain J, Martinod K, Wong SL, Cifuni SM, Schattner M, Wagner DD. Brief Report P-selectin promotes neutrophil extracellular trap formation in mice. Blood. 2018;126(14):242–247. doi:10.1182/blood-2015-01-624023.The.
   Google Scholar
• Pfeiler S, Stark K, Massberg S, Engelmann B. Propagation of thrombosis by neutrophils and extracellular nucleosome networks. Haematologica. 2017;102(2):206–213. doi:10.3324/haematol.2016.142471.
   PubMed Web of Science ®Google Scholar
• Jablonska J, Lang S, Sionov RV, et al. The regulation of pre-metastatic niche formation by neutrophils. Oncotarget. 2017;8(67):112132–112144. doi:10.18632/oncotarget.22792.
   PubMedGoogle Scholar
• Corriden R, Hollands A, Olson J, Derieux J, Lopez J, Chang JT, Gonzalez DJ, Nizet V. Tamoxifen augments the innate immune function of neutrophils through modulation of intracellular ceramide. Nat Commun. 2015;6:8369. doi:10.1038/ncomms9369.
   PubMed Web of Science ®Google Scholar
• Flores R, Döhrmann S, Schaal C, Hakkim A, Nizet V, Corriden R. The selective estrogen receptor modulator raloxifene inhibits neutrophil extracellular trap formation. Front Immunol. 2016;7:556. doi:10.3389/fimmu.2016.00566.
   PubMed Web of Science ®Google Scholar